Relmada Therapeutics (RLMD) null Earnings

23MarConfirmed
May 20
Aug 20
Nov 20
Mar 21
-1.31
-1.01
-0.72
-0.42

Details

Expected EPS
-1.16
Actual EPS
-1.31
Surprise EPS
-0.15
Surprise Percent
+12.93%

Description

Relmada Therapeutics (RLMD) has reported earnings of -1.31 per share for .

0 Comments

Share your thoughts